Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 303,000 shares at $4.57 ($1.3M) on 2018-12-06, disclosed to the SEC on 2018-12-10.
Open-market sale of $1.3M TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 27,000 | $0 | 0.0% |
| 2 | $4.57 | 92,000 | $420K | 33.2% |
| 3 | $4.60 | 92,000 | $423K | 33.4% |
| 4 | $4.60 | 92,000 | $423K | 33.4% |
| Total | $4.18 avg | 303,000 | $1.3M | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |